AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2668979 — intervention group
Group type: COMPARATOR
Intervention: Imipramine 25 mg tablets
Number of subjects: 40
Study 2668979 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 40
Study 129494 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral tetracycline (500 mg/day)
Number of subjects: 20
Study 129494 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical tetracycline (0.5% solution applied twice daily)
Number of subjects: 20
Study 129494 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 31345967 — intervention group
Group type: EXPERIMENTAL
Intervention: Video consent tool
Number of subjects: 20
Study 27550719 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-restricted feeding (TRF)
Number of subjects: 0
Study 27550719 — intervention group
Group type: COMPARATOR
Intervention: Resistance training (RT) without TRF
Number of subjects: 0
Study 26083150 — intervention group
Group type: EXPERIMENTAL
Intervention: MID-ART (Test)
Number of subjects: 254
Study 26083150 — intervention group
Group type: COMPARATOR
Intervention: Standard care (Control)
Number of subjects: 254
Study 26083150 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 254
Study 22684372 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric ankle dorsi flexion training
Number of subjects: 26
Study 22684372 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotonic ankle dorsi flexion training
Number of subjects: 26
Study 22684372 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotonic plantar flexion training
Number of subjects: 26
Study 22684372 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric plantar flexion training
Number of subjects: 26
Study 22684372 — intervention group
Group type: EXPERIMENTAL
Intervention: All training exercise protocols
Number of subjects: 26
Study 21940742 — intervention group
Group type: EXPERIMENTAL
Intervention: New multimodal system (SAFERSleep)
Number of subjects: 89
Study 21940742 — intervention group
Group type: COMPARATOR
Intervention: Conventional methods
Number of subjects: 89
Study 21940742 — intervention group
Group type: EXPERIMENTAL
Intervention: New multimodal system (SAFERSleep) with key principles applied
Number of subjects: 89
Study 21940742 — intervention group
Group type: EXPERIMENTAL
Intervention: New multimodal system (SAFERSleep) without key principles applied
Number of subjects: 89
Study 19532133 — intervention group
Group type: EXPERIMENTAL
Intervention: Wire-guided cannulation technique
Number of subjects: 5
Study 19532133 — intervention group
Group type: COMPARATOR
Intervention: Standard cannulation technique
Number of subjects: 5
Study 17165243 — intervention group
Group type: COMPARATOR
Intervention: Immediate-release nicotinic acid
Number of subjects: 5000
Study 17165243 — intervention group
Group type: COMPARATOR
Intervention: Sustained-release nicotinic acid
Number of subjects: 5000
Study 15233807 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% cyclosporine (CsA) reduction, n = 16
Number of subjects: 31
Study 15233807 — intervention group
Group type: COMPARATOR
Intervention: Control group (continued CsA dose), n = 15
Number of subjects: 31
Study 11277680 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention worksites
Number of subjects: 28
Study 11277680 — intervention group
Group type: COMPARATOR
Intervention: Control worksites
Number of subjects: 28
Study 9215121 — intervention group
Group type: EXPERIMENTAL
Intervention: Tyramide enhanced avidin‐biotin immunostaining method
Number of subjects: 19
Study 9215121 — intervention group
Group type: COMPARATOR
Intervention: Standard avidin‐biotin immunostaining methods
Number of subjects: 19
Study 8251351 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium lauryl sulphate (SLS) patch test
Number of subjects: 15
Study 8251351 — intervention group
Group type: EXPERIMENTAL
Intervention: Mantoux test (tuberculin injection)
Number of subjects: 15
Study 8251351 — intervention group
Group type: COMPARATOR
Intervention: Control sites (uninvolved skin > 7 cm distant from test sites)
Number of subjects: 15
Study 3300248 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sustained-release isosorbide dinitrate (ISDN), 20 to 40 mg twice daily
Number of subjects: 40
Study 3300248 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 31374188 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-positive women on ART
Number of subjects: 38
Study 31374188 — intervention group
Group type: COMPARATOR
Intervention: HIV-negative women initiating DMPA
Number of subjects: 38
Study 28421648 — intervention group
Group type: EXPERIMENTAL
Intervention: Response imagery
Number of subjects: 215
Study 28421648 — intervention group
Group type: EXPERIMENTAL
Intervention: Response imagery with verbal suggestion
Number of subjects: 215
Study 28421648 — intervention group
Group type: EXPERIMENTAL
Intervention: Response imagery only
Number of subjects: 215
Study 28421648 — intervention group
Group type: COMPARATOR
Intervention: Control imagery
Number of subjects: 215
Study 28421648 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 215
Study 26641854 — intervention group
Group type: EXPERIMENTAL
Intervention: Body Project intervention
Number of subjects: 0
Study 26641854 — intervention group
Group type: COMPARATOR
Intervention: Educational control condition
Number of subjects: 0
Study 24165561 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention arm (HIV prevention trial)
Number of subjects: 4505
Study 24165561 — intervention group
Group type: COMPARATOR
Intervention: Control arm (HIV prevention trial)
Number of subjects: 4505
Study 24165561 — intervention group
Group type: EXPERIMENTAL
Intervention: Both arms (HIV prevention trial)
Number of subjects: 4505
Study 20421151 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton beam therapy and capecitabine (825 mg/m² b.i.d. for 10 days)
Number of subjects: 15
Study 20421151 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton beam therapy and capecitabine
Number of subjects: 15
Study 18653493 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 300 mg
Number of subjects: 120
Study 18653493 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 300 mg + Dexamethasone 8 mg
Number of subjects: 120
Study 18653493 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 16932227 — intervention group
Group type: EXPERIMENTAL
Intervention: Open lung concept (OLC) ventilation with total PEEP of 14 +/- 4 cm H2O
Number of subjects: 28
Study 16932227 — intervention group
Group type: COMPARATOR
Intervention: Conventional ventilation with total PEEP of 5 cm H2O
Number of subjects: 28
Study 15282656 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 100
Study 15282656 — intervention group
Group type: COMPARATOR
Intervention: Heparin (UFH)
Number of subjects: 100
Study 11243639 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum bFGF levels in vitiligo patients
Number of subjects: 20
Study 11243639 — intervention group
Group type: EXPERIMENTAL
Intervention: Suction blister fluid bFGF levels in vitiligo patients
Number of subjects: 20
Study 11243639 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls (3 females, 8 males)
Number of subjects: 20
Study 9068534 — intervention group
Group type: EXPERIMENTAL
Intervention: Right ventricular septal pacing in VDD mode at atrioventricular delays of 100 to 200 ms
Number of subjects: 13
Study 9068534 — intervention group
Group type: COMPARATOR
Intervention: Intrinsic rhythm
Number of subjects: 13
Study 8222739 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled-release ketoprofen tablets (200 mg)
Number of subjects: 83
Study 8222739 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin suppository (100 mg)
Number of subjects: 83
Study 3100675 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 200 mg
Number of subjects: 202
Study 3100675 — intervention group
Group type: EXPERIMENTAL
Intervention: Codeine phosphate 15 mg
Number of subjects: 202
Study 3100675 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen/codeine combination
Number of subjects: 202
Study 3100675 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 600 mg
Number of subjects: 202
Study 3100675 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 202
Study 30982715 — intervention group
Group type: EXPERIMENTAL
Intervention: GR_COPD program
Number of subjects: 158
Study 30982715 — intervention group
Group type: COMPARATOR
Intervention: Control group (patients who declined the GR_COPD program)
Number of subjects: 158
Study 29530385 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer-based step count prescription strategy
Number of subjects: 20
Study 29530385 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer-based monitoring combined with step count prescriptions
Number of subjects: 20
Study 29530385 — intervention group
Group type: EXPERIMENTAL
Intervention: Strategies to integrate more steps into routines
Number of subjects: 20
Study 29530385 — intervention group
Group type: EXPERIMENTAL
Intervention: Challenges faced by participants who decreased step counts
Number of subjects: 20
Study 29530385 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician-delivered strategy
Number of subjects: 20
Study 27578294 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-based health coaching program (10 sessions)
Number of subjects: 710
Study 27578294 — intervention group
Group type: COMPARATOR
Intervention: Information only
Number of subjects: 710
Study 24469645 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (daily hydration of 2500 mL, ciprofloxacin, diclofenac sodium, spasmolytic agent)
Number of subjects: 127
Study 24469645 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment + tamsulosin 0.4 mg orally daily for 4 weeks
Number of subjects: 127
Study 24469645 — intervention group
Group type: EXPERIMENTAL
Intervention: Ureteroscopy
Number of subjects: 127
Study 21915740 — intervention group
Group type: EXPERIMENTAL
Intervention: PEERS intervention (caregiver-assisted social skills training)
Number of subjects: 0
Study 20513779 — intervention group
Group type: EXPERIMENTAL
Intervention: High-quality guideline content
Number of subjects: 30
Study 20513779 — intervention group
Group type: COMPARATOR
Intervention: Low-quality guideline content
Number of subjects: 30
Study 20513779 — intervention group
Group type: EXPERIMENTAL
Intervention: User's manual of AGREE II
Number of subjects: 30
Study 18058410 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingency Management (CM)
Number of subjects: 0
Study 18058410 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 0
Study 16101362 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical periodontal treatments (four different surgical procedures)
Number of subjects: 40
Study 16101362 — intervention group
Group type: COMPARATOR
Intervention: Control group (persons without periodontitis)
Number of subjects: 40
Study 12116341 — intervention group
Group type: EXPERIMENTAL
Intervention: Flow cytometric analysis of neoplastic cases
Number of subjects: 167
Study 12116341 — intervention group
Group type: COMPARATOR
Intervention: Control cases
Number of subjects: 167
Study 10890478 — intervention group
Group type: EXPERIMENTAL
Intervention: HES 130/0.4 (n = 10)
Number of subjects: 20
Study 10890478 — intervention group
Group type: COMPARATOR
Intervention: HES 200/0.5 (n = 10)
Number of subjects: 20
Study 10890478 — intervention group
Group type: EXPERIMENTAL
Intervention: HES 130/0.4
Number of subjects: 20
Study 10890478 — intervention group
Group type: COMPARATOR
Intervention: HES 200/0.5
Number of subjects: 20
Study 8968446 — intervention group
Group type: EXPERIMENTAL
Intervention: BMY 21,502
Number of subjects: 69
Study 8968446 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study 8968446 — intervention group
Group type: EXPERIMENTAL
Intervention: BMY 21,502 (moderate dementia subgroup)
Number of subjects: 69
Study 8968446 — intervention group
Group type: COMPARATOR
Intervention: Placebo (moderate dementia subgroup)
Number of subjects: 69
Study 1453290 — intervention group
Group type: EXPERIMENTAL
Intervention: Group I: 2 grams of Cefazolin IV and abdomino-peritoneal irrigation with saline
Number of subjects: 308
Study 1453290 — intervention group
Group type: COMPARATOR
Intervention: Group II: 1 gram of Cefazolin IV and 1 gram in saline irrigation solution
Number of subjects: 308
Study 6377793 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of methyldopa/hydrochlorothiazide/amiloride (M/HCT/A)
Number of subjects: 41
Study 6377793 — intervention group
Group type: COMPARATOR
Intervention: Methyldopa (M)
Number of subjects: 41
Study 6377793 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide/amiloride (HCT/A)
Number of subjects: 41
Study 29893596 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (120,000 IU over 1 week)
Number of subjects: 67
Study 29893596 — intervention group
Group type: COMPARATOR
Intervention: Placebo (inert pills)
Number of subjects: 67
Study 29893596 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 67
Study 29644871 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention teams with a PC representative attending discharge rounds twice a week
Number of subjects: 0
Study 29644871 — intervention group
Group type: COMPARATOR
Intervention: Control teams with unenhanced discharge rounds
Number of subjects: 0
Study 27470399 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin (1g/day for 8 weeks)
Number of subjects: 117
Study 27470399 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117
Study 27470399 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin
Number of subjects: 117
Study 25247517 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized, interactive decision-support guide and access to prenatal testing with no out-of-pocket expense (n=357)
Number of subjects: 710
Study 25247517 — intervention group
Group type: COMPARATOR
Intervention: Usual care as per current guidelines (n=353)
Number of subjects: 710
Study 23180520 — intervention group
Group type: EXPERIMENTAL
Intervention: RVA pacing
Number of subjects: 65
Study 23180520 — intervention group
Group type: COMPARATOR
Intervention: RVOTS pacing
Number of subjects: 65
Study 20492467 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 0
Study 20492467 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 0
Study 18614728 — intervention group
Group type: EXPERIMENTAL
Intervention: Porridge with energy density of 0.5 kcal/g
Number of subjects: 18
Study 18614728 — intervention group
Group type: EXPERIMENTAL
Intervention: Porridge with energy density of 1.0 kcal/g
Number of subjects: 18
Study 18614728 — intervention group
Group type: EXPERIMENTAL
Intervention: Porridge with energy density of 1.5 kcal/g
Number of subjects: 18
Study 18614728 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 meals/day
Number of subjects: 18
Study 18614728 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 meals/day
Number of subjects: 18
Study 18614728 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 meals/day
Number of subjects: 18
Study 18614728 — intervention group
Group type: EXPERIMENTAL
Intervention: All energy densities and feeding frequencies
Number of subjects: 18
Study 16100179 — intervention group
Group type: EXPERIMENTAL
Intervention: Prefixed equimolar nitrous oxide/oxygen mixture (N2O)
Number of subjects: 206
Study 16100179 — intervention group
Group type: COMPARATOR
Intervention: Prefixed equimolar nitrogen and oxygen mixture (control)
Number of subjects: 206
Study 12427060 — intervention group
Group type: EXPERIMENTAL
Intervention: 12‐hour self‐management program (n = 86)
Number of subjects: 231
Study 12427060 — intervention group
Group type: COMPARATOR
Intervention: Tape‐recorded health lectures (n = 74)
Number of subjects: 231
Study 12427060 — intervention group
Group type: COMPARATOR
Intervention: Waiting list (n = 72)
Number of subjects: 231
Study 10094750 — intervention group
Group type: EXPERIMENTAL
Intervention: 90 degrees OATV angle
Number of subjects: 10
Study 10094750 — intervention group
Group type: EXPERIMENTAL
Intervention: 45 degrees OATV angle
Number of subjects: 10
Study 10094750 — intervention group
Group type: EXPERIMENTAL
Intervention: OATV angles (90, 75, 60, 45 degrees)
Number of subjects: 10
Study 8949813 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 0.1 mg
Number of subjects: 0
Study 8949813 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 3.3 mg
Number of subjects: 0
Study 8949813 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 0
Study 31823545 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial group (screw implantation via vertebral arch-transverse pathway)
Number of subjects: 24
Study 31823545 — intervention group
Group type: COMPARATOR
Intervention: Control group (traditional screw implantation technology)
Number of subjects: 24
Study 31823545 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial group
Number of subjects: 24
Study 31823545 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study 28231824 — intervention group
Group type: EXPERIMENTAL
Intervention: Vestibular rehabilitation with auditory biofeedback
Number of subjects: 0
Study 28231824 — intervention group
Group type: COMPARATOR
Intervention: Vestibular rehabilitation without auditory biofeedback
Number of subjects: 0
Study 25695341 — intervention group
Group type: EXPERIMENTAL
Intervention: CGM self-efficacy score >80
Number of subjects: 120
Study 25695341 — intervention group
Group type: COMPARATOR
Intervention: CGM self-efficacy score ≤80
Number of subjects: 120
Study 23761651 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 g/d of hazelnuts
Number of subjects: 107
Study 23761651 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 g/d of hazelnuts
Number of subjects: 107
Study 23761651 — intervention group
Group type: COMPARATOR
Intervention: No nuts (control group)
Number of subjects: 107
Study 20422422 — intervention group
Group type: EXPERIMENTAL
Intervention: Hysterectomy plus pelvic lymphadenectomy
Number of subjects: 38
Study 20422422 — intervention group
Group type: COMPARATOR
Intervention: Hysterectomy
Number of subjects: 38
Study 18719630 — intervention group
Group type: EXPERIMENTAL
Intervention: Childhood BMI (kg/m(2))
Number of subjects: 2802
Study 18719630 — intervention group
Group type: EXPERIMENTAL
Intervention: Childhood height (cm)
Number of subjects: 2802
Study 18719630 — intervention group
Group type: EXPERIMENTAL
Intervention: Tall children with high BMI
Number of subjects: 2802
Study 15996416 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream applied three times per week for 16 weeks
Number of subjects: 146
Study 15996416 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream applied two times per week for 16 weeks
Number of subjects: 146
Study 15996416 — intervention group
Group type: COMPARATOR
Intervention: Baseline AK lesions
Number of subjects: 146
Study 15996416 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod treatment
Number of subjects: 146
Study 12861143 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogen (0.625 mg)
Number of subjects: 57
Study 12861143 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene (60 mg)
Number of subjects: 57
Study 12861143 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen (20 mg)
Number of subjects: 57
Study 12861143 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study 10653205 — intervention group
Group type: EXPERIMENTAL
Intervention: Reboxetine
Number of subjects: 52
Study 10653205 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 8843209 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (1800 mg/day, timed-release formulation)
Number of subjects: 100
Study 8843209 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 1355585 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatostatin analogues (e.g., octreotide)
Number of subjects: 0
Study 6711468 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice as the major carbohydrate source
Number of subjects: 8
Study 6711468 — intervention group
Group type: COMPARATOR
Intervention: Potato as the major carbohydrate source
Number of subjects: 8
Study 31368267 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural analgesia (PCEA, Sufentainil + 0.1% Ropivacaine hydrochloride, 5 µg/mL at L3‐L4 interspace)
Number of subjects: 80
Study 31368267 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupoint injection of Ropivacaine (0.2%, 1 mL/acupoint at LI4 and SP6)
Number of subjects: 80
Study 31368267 — intervention group
Group type: COMPARATOR
Intervention: Control group (no analgesia)
Number of subjects: 80
Study 29574681 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-directed haemodynamic therapy (colloid solution, dobutamine, ephedrine, or norepinephrine)
Number of subjects: 62
Study 29574681 — intervention group
Group type: COMPARATOR
Intervention: Conventional haemodynamic therapy (extra bolus fluid and ephedrine or norepinephrine)
Number of subjects: 62
Study 26159058 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity (HI; acceleration of all treadmill slips=12m/s(2))
Number of subjects: 36
Study 26159058 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity (LO; acceleration of all treadmill slips=6m/s(2))
Number of subjects: 36
Study 26159058 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressively increasing intensity (INCR; acceleration of treadmill slips increasing from 6m/s(2) to 12m/s(2))
Number of subjects: 36
Study 26159058 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressively decreasing intensity (DECR; acceleration of treadmill slips decreasing from 12m/s(2) to 6m/s(2))
Number of subjects: 36
Study 26159058 — intervention group
Group type: COMPARATOR
Intervention: Control group (CTRL, n=9)
Number of subjects: 36
Study 24377663 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical muscle stimulation (EMS)
Number of subjects: 11
Study 22826982 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic injection therapy with diluted epinephrine (group I)
Number of subjects: 58
Study 22826982 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy of epinephrine and hemoclips (group II)
Number of subjects: 58
Study 20585051 — intervention group
Group type: EXPERIMENTAL
Intervention: Text-comprehension (TC) training
Number of subjects: 0
Study 20585051 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral-language (OL) training
Number of subjects: 0
Study 20585051 — intervention group
Group type: EXPERIMENTAL
Intervention: TC and OL training combined (COM)
Number of subjects: 0